Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID-19 pandemic: A multicenter, two-arm, real-world study
10.1002/clt2.12122
Saved in:
Main Authors: | Zhou, S, Liu, Y, Xue, J, Tang, J, Yu, Q, Qu, S, Zhang, S, Mo, B, Li, J, Yang, Y, Wang, DY, Qiu, Q |
---|---|
Other Authors: | OTOLARYNGOLOGY |
Format: | Letter |
Published: |
Wiley
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/227542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical Efficacy Evaluation of 1-Year Subcutaneous Immunotherapy for Artemisia sieversiana Pollen Allergic Rhinitis by Serum Metabolomics
by: Shi, H.-Y., et al.
Published: (2021) -
The efficacy of sublingual immunotherapy for allergic diseases in Asia
by: Liu, X., et al.
Published: (2021) -
Safety Profile and Issues of Subcutaneous Immunotherapy in The Treatment of Children with Allergic Rhinitis
by: Anang Endaryanto, -, et al.
Published: (2022) -
Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
by: Tipyapa Rattanamanee, et al.
Published: (2022) -
Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children
by: Rattanamanee T.
Published: (2023)